Search
shopping
Search
Menu

Goal and Learning Outcomes

The goal of this program is to provide all Florida nurse licensees and those who are interested in earning a license in Florida with a basic overview of the Florida Nurse Practice Act and its rules. After studying the information presented here, you will be able to:
  • List the rights and responsibilities of the Florida Board of Nursing.
  • Differentiate practices between licensed practical nursing, registered nursing, and advanced practice nursing.
  • Outline at least three practice requirements of Florida nurse licensees.
  • Describe continuing education (CE) requirements for Florida nurse licensees.
  • List and discuss at least six grounds for discipline of any Florida nurse licensee.
  • Explain the role of Florida’s Intervention Project for Nurses.
  • Identify implications of the enhanced Nurse Licensure Compact (eNLC).

Course Authors

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.